BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral
BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral
Read moreFri, 19th Mar 2021 12:26
BROKER RATINGS: UBS raises Rightmove to buy, Computacenter to neutral
Read more(Sharecast News) - Futura Medical shares surged on Monday after the company said it had agreed with the US Food and Drug Administration on the protocol for a small confirmatory clinical study of its erectile dysfunction gel, MED3000.
Read moreFutura Medical shares jump as erectile dysfunction drug nears approval
Read moreAIM WINNERS & LOSERS: Futura Medical up on EU medical device clearance
Read moreTRADING UPDATES: Futura signs development deal; UKOG gets day in court
Read moreAIM WINNERS & LOSERS: Futura Medical rises on financing transaction
Read moreIN BRIEF: Futura Medical Progresses MED3000 Regulatory Process
Read more(Sharecast News) - Pharmaceutical company Futura Medical updated the market on regulatory processes and commercial activities for MED3000 - its topical gel formulation for treatment of erectile dysfunction (ED).
Read moreUK TRADING UPDATE SUMMARY: Quartix Annual Earnings To Beat Consensus
Read moreIN BRIEF: Futura Medical Loss Narrows As MED3000 Approval Nears
Read more(Sharecast News) - Futura Medical reported a net loss of £1.06m in its first half on Wednesday, narrowing from a net loss of £4.46m year-on-year.
Read moreUK Earnings, Trading Statements Calendar - Next 7 Days
Read moreIN BRIEF: Positive QMS Opinion For Futura Medical's MED3000
Read moreUK TRADING UPDATE SUMMARY: Brickability Recovering Well From Pandemic
Read more